Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
about
Immune Responses Against Classical Swine Fever Virus: Between Ignorance and LunacyStructures and Functions of Pestivirus Glycoproteins: Not Simply Surface MattersClassical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines.Activation and modulation of antiviral and apoptotic genes in pigs infected with classical swine fever viruses of high, moderate or low virulenceLow temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formationClassical Swine Fever-An Updated ReviewThe M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.Modelling the effectiveness and risks of vaccination strategies to control classical swine fever epidemics.Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.Present and future of veterinary viral vaccinology: a review.Analysis of genes expression of Spodoptera exigua larvae upon AcMNPV infection.Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in ChinaGeneration and efficacy evaluation of recombinant classical swine fever virus E2 glycoprotein expressed in stable transgenic mammalian cell line.Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge.Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication.Characterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza.Insect cell technology is a versatile and robust vaccine manufacturing platform.Classical swine fever in pigs: recent developments and future perspectives.Enzyme-linked immunosorbent assay using a virus type-specific peptide based on a subdomain of envelope protein E(rns) for serologic diagnosis of pestivirus infections in swine.Molecular characterization of E2 glycoprotein of classical swine fever virus: adaptation and propagation in porcine kidney cells.Development of multiple ELISAs for the detection of antibodies against classical swine fever virus in pig sera.Production of classical swine fever virus envelope glycoprotein E2 as recombinant polyhedra in baculovirus-infected silkworm larvae.Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples.Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine.Control and eradication of Classic Swine Fever in wild boarAnimal health safety of fresh meat derived from pigs vaccinated against Classic Swine FeverA Review of Classical Swine Fever Virus and Routes of Introduction into the United States and the Potential for Virus Establishment.Towards the development of a one-dose classical swine fever subunit vaccine: antigen titration, onset and duration of immunity.
P2860
Q26776096-A49A508A-3EDD-445A-B219-3B40FAAA9115Q26860412-65EA6DF4-F405-4F75-8EB0-0BA1C0A83D21Q27469643-08C30985-C856-4DDD-9EF2-5B28A6436167Q27489617-6A235148-F8EE-4DFC-985C-8E44CE076DECQ28744320-78CFDE14-5D74-4BEA-87FF-C84BB268D08CQ30234718-D1F339FF-A11A-4757-979E-14C3D258A3B0Q33525023-D0A1FFB0-DFC3-4856-BBE0-7512304A80B1Q33726680-872E3D5C-DD12-4851-9914-EB94B076911FQ33962565-522061B0-0E09-4598-9D71-128577854D45Q34087342-D3A18936-F300-41F0-81BB-E12AEC85D106Q34341579-F83C5AD3-8DB3-4541-8297-F5C22DFCFE63Q34364896-784794EB-B022-461D-BFB3-0B371826D03DQ34515455-340CB0F7-7D86-42AC-8A74-CC28E9CFFB1FQ35242493-9A527897-3E88-47D4-85B0-33DDCA5E8E44Q36128897-77B40E35-6928-4983-8CB3-D6B5E8B1B20BQ36177381-FC446EC3-74A6-4979-AF5F-F2EFFACFE475Q36550140-EE2EED00-754E-407A-9395-386C60B18940Q37658883-16810DEB-68F6-4103-9589-62510833B059Q37909427-A70DE724-73BE-46A5-AE07-18A3DB09453BQ38326027-EF3E18FE-488F-48DB-96A4-61ACA6B5BE7DQ39463639-68EB6871-EA7A-4EA9-84BC-B165E88F1A34Q40175379-DD3827CA-645A-442F-8F26-D7B7127ABD4DQ40298501-F42DBFDB-F13E-40A9-BF86-5ED93FBF75F5Q40320499-9362E3E9-2C9F-4D82-BCDA-8B585C0C57F9Q40494105-E8B7677A-1E01-4D7D-9F8F-DF361ABDEBA6Q40616396-4D3FC81C-BE38-4CD7-B2AA-F50E42685FF9Q47146243-25A8F203-C158-458A-B077-D15643C4E117Q47147214-EE514C17-388F-4CD1-9673-B0BC44D79EDAQ51146467-FD10F95C-BB16-43A0-8A15-3CCD1B55604EQ51743820-93A6CEC9-DC20-4E7D-81C7-B3CA90A44C6D
P2860
Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Efficacy and stability of a su ...... f classical swine fever virus.
@en
type
label
Efficacy and stability of a su ...... f classical swine fever virus.
@en
prefLabel
Efficacy and stability of a su ...... f classical swine fever virus.
@en
P2093
P1476
Efficacy and stability of a su ...... f classical swine fever virus.
@en
P2093
Moormann RJ
Terpstra C
de Kluijver EP
de Smit AJ
P304
P356
10.1016/S0378-1135(99)00003-6
P577
1999-04-01T00:00:00Z